Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review
BackgroundPlatinum-based chemotherapy bring severe hematological toxicity that can lead to dose reduction or discontinuation of therapy. Genetic variations have been reported to influence the risk and extent of hematological toxicity; however, the results are controversial and a comprehensive overvi...
Saved in:
Main Authors: | Yi Zheng (Author), Mimi Tang (Author), Zheng Deng (Author), Pei Cai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neglected, Drug-Induced Platinum Accumulation Causes Immune Toxicity
by: Yuling Zhang, et al.
Published: (2020) -
The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis
by: Zaiwei Song, et al.
Published: (2021) -
Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
by: Afifah NN, et al.
Published: (2020) -
Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis
by: Woorim Kim, et al.
Published: (2022) -
Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer
by: Xuan Huang, et al.
Published: (2023)